Literature DB >> 31227609

Multiplicative fitness, rapid haplotype discovery, and fitness decay explain evolution of human MHC.

Alexander E Lobkovsky1, Lee Levi2, Yuri I Wolf1, Martin Maiers3, Loren Gragert3,4, Idan Alter2, Yoram Louzoun5, Eugene V Koonin6.   

Abstract

The major histocompatibility complex (MHC) is a central component of the vertebrate immune system and hence evolves in the regime of a host-pathogen evolutionary race. The MHC is associated with quantitative traits which directly affect fitness and are subject to selection pressure. The evolution of haplotypes at the MHC HLA (HLA) locus is generally thought to be governed by selection for increased diversity that is manifested in overdominance and/or negative frequency-dependent selection (FDS). However, recently, a model combining purifying selection on haplotypes and balancing selection on alleles has been proposed. We compare the predictions of several population dynamics models of haplotype frequency evolution to the distributions derived from 6.59-million-donor HLA typings from the National Marrow Donor Program registry. We show that models that combine a multiplicative fitness function, extremely high haplotype discovery rates, and exponential fitness decay over time produce the best fit to the data for most of the analyzed populations. In contrast, overdominance is not supported, and population substructure does not explain the observed haplotype frequencies. Furthermore, there is no evidence of negative FDS. Thus, multiplicative fitness, rapid haplotype discovery, and rapid fitness decay appear to be the major factors shaping the HLA haplotype frequency distribution in the human population.

Entities:  

Keywords:  fitness decay; frequency-dependent selection; haplotype discovery; haplotype evolution; multiplicative fitness

Year:  2019        PMID: 31227609      PMCID: PMC6628782          DOI: 10.1073/pnas.1714436116

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  39 in total

1.  Balancing selection at closely linked, overdominant loci in a finite population.

Authors:  M Slatkin
Journal:  Genetics       Date:  2000-03       Impact factor: 4.562

Review 2.  How selection shapes variation of the human major histocompatibility complex: a review.

Authors:  D Meyer; G Thomson
Journal:  Ann Hum Genet       Date:  2001-01       Impact factor: 1.670

3.  Overdominant vs. frequency-dependent selection at MHC loci.

Authors:  R W Slade; H I McCallum
Journal:  Genetics       Date:  1992-11       Impact factor: 4.562

Review 4.  The evolutionary ecology of the major histocompatibility complex.

Authors:  S B Piertney; M K Oliver
Journal:  Heredity (Edinb)       Date:  2006-01       Impact factor: 3.821

5.  Maintenance of MHC polymorphism.

Authors:  A L Hughes; M Nei
Journal:  Nature       Date:  1992-01-30       Impact factor: 49.962

6.  Mating patterns in seminatural populations of mice influenced by MHC genotype.

Authors:  W K Potts; C J Manning; E K Wakeland
Journal:  Nature       Date:  1991-08-15       Impact factor: 49.962

7.  Polymorphism and balancing selection at major histocompatibility complex loci.

Authors:  N Takahata; Y Satta; J Klein
Journal:  Genetics       Date:  1992-04       Impact factor: 4.562

Review 8.  Comparative genomics of major histocompatibility complexes.

Authors:  James Kelley; Lutz Walter; John Trowsdale
Journal:  Immunogenetics       Date:  2004-12-18       Impact factor: 2.846

9.  A high-resolution HLA and SNP haplotype map for disease association studies in the extended human MHC.

Authors:  Paul I W de Bakker; Gil McVean; Pardis C Sabeti; Marcos M Miretti; Todd Green; Jonathan Marchini; Xiayi Ke; Alienke J Monsuur; Pamela Whittaker; Marcos Delgado; Jonathan Morrison; Angela Richardson; Emily C Walsh; Xiaojiang Gao; Luana Galver; John Hart; David A Hafler; Margaret Pericak-Vance; John A Todd; Mark J Daly; John Trowsdale; Cisca Wijmenga; Tim J Vyse; Stephan Beck; Sarah Shaw Murray; Mary Carrington; Simon Gregory; Panos Deloukas; John D Rioux
Journal:  Nat Genet       Date:  2006-09-24       Impact factor: 38.330

10.  Combinations of maternal KIR and fetal HLA-C genes influence the risk of preeclampsia and reproductive success.

Authors:  Susan E Hiby; James J Walker; Kevin M O'shaughnessy; Christopher W G Redman; Mary Carrington; John Trowsdale; Ashley Moffett
Journal:  J Exp Med       Date:  2004-10-11       Impact factor: 14.307

View more
  6 in total

1.  Single haplotype admixture models using large scale HLA genotype frequencies to reproduce human admixture.

Authors:  Alexandra Litinsky Simanovsky; Abeer Madbouly; Michael Halagan; Martin Maiers; Yoram Louzoun
Journal:  Immunogenetics       Date:  2019-11-18       Impact factor: 2.846

2.  Evolution of the human MHC: New haplotype frequency analysis is not informative.

Authors:  Philip W Hedrick; William Klitz
Journal:  Proc Natl Acad Sci U S A       Date:  2019-10-29       Impact factor: 11.205

3.  Reply to Hedrick and Klitz: High haplotype discovery rate in the HLA locus.

Authors:  Yoram Louzoun; Alexander E Lobkovsky; Lee Levi; Yuri I Wolf; Martin Maiers; Loren Gragert; Idan Alter; Eugene V Koonin
Journal:  Proc Natl Acad Sci U S A       Date:  2019-10-29       Impact factor: 11.205

4.  Comprehensive Analysis of CD4+ T Cell Responses to CMV pp65 Antigen Restricted by Single HLA-DR, -DQ, and -DP Allotype Within an Individual.

Authors:  You-Seok Hyun; Hyeong-A Jo; Yong-Hun Lee; Sun-Mi Kim; In-Cheol Baek; Hyun-Jung Sohn; Hyun-Il Cho; Tai-Gyu Kim
Journal:  Front Immunol       Date:  2021-02-15       Impact factor: 7.561

5.  The giant axolotl genome uncovers the evolution, scaling, and transcriptional control of complex gene loci.

Authors:  Siegfried Schloissnig; Akane Kawaguchi; Sergej Nowoshilow; Francisco Falcon; Leo Otsuki; Pietro Tardivo; Nataliya Timoshevskaya; Melissa C Keinath; Jeramiah James Smith; S Randal Voss; Elly M Tanaka
Journal:  Proc Natl Acad Sci U S A       Date:  2021-04-13       Impact factor: 11.205

6.  MHC Haplotyping of SARS-CoV-2 Patients: HLA Subtypes Are Not Associated with the Presence and Severity of COVID-19 in the Israeli Population.

Authors:  Shay Ben Shachar; Noam Barda; Sigal Manor; Sapir Israeli; Noa Dagan; Shai Carmi; Ran Balicer; Bracha Zisser; Yoram Louzoun
Journal:  J Clin Immunol       Date:  2021-05-29       Impact factor: 8.317

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.